The purpose of this study was to determine, by analyzing the pressure-volume relationship, the prognostic value of parameters related to myocardial energetics for predicting mortality in patients with dilated cardiomyopathy (DCM) in sinus rhythm. BACKGROUND The relationship between the myocardial energetics and the prognosis of patients with DCM in sinus rhythm remains unclear.
Dilated cardiomyopathy (DCM) is characterized by progressive left ventricular (LV) dilation and severely depressed LV systolic function. It eventually culminates in end-stage congestive heart failure and cardiac death (1, 2) . Therefore, it is essential to identify, as early as possible, patients who are unlikely to improve or stabilize with standard medical treatment. Several studies have attempted to find clinical and laboratory abnormalities associated with poorer prognosis. These have included indices related to LV systolic and diastolic function such as LV ejection fraction (LVEF), LV end-diastolic dimensions and pressures and transmitral inflow characteristics (2) (3) (4) (5) . One of the limitations of these markers, however, is their load-dependence (6) , which may confound accurate assessment of LV systolic or diastolic function and limit their predictive value. Recent studies have focused on myocardial energetics as well as myocardial function to elucidate the pathophysiology of DCM (7) (8) (9) (10) . Analysis of the pressure-volume relationship provides a better understanding of the myocardial energetics and enables a fuller appreciation of the impaired energy generation in the diseased heart, which may be associated with a poor prognosis in patients with DCM. However, no previous studies have evaluated the relationship between myocardial energetics and the prognosis of patients with DCM.
Atrial fibrillation (AF) is common in patients with DCM and is associated with a variety of potentially deleterious hemodynamic consequences that might exert a negative influence on prognosis and accelerate the progression of LV systolic dysfunction (11, 12) . The overall survival rate for patients in sinus rhythm has been found to be higher than the rate for patients with AF (13) . However, the prognostic indicators in patients with DCM in sinus rhythm remain unclear.
Accordingly, the purpose of this study was to determine the prognostic value of myocardial energetics for predicting mortality in patients with DCM in sinus rhythm by directly measuring myocardial oxygen consumption and analyzing the pressure-volume relationship.
METHODS
Patient population. The study population consisted of 114 consecutive ambulatory patients with nonischemic DCM in sinus rhythm who were referred to Nagoya University Hospital between February 1983 and October 1999. Dilated cardiomyopathy was defined as a decreased LVEF (Ͻ50% as determined by contrast ventriculography) and a dilated LV cavity in the absence of significant coronary artery stenosis (Ͼ50% as determined by coronary angiography) or valvular heart disease, arterial hypertension, or cardiac muscle disease caused by any known systemic disease (14) . A right or left ventricular biopsy was obtained to confirm the diagnosis of DCM. Patients with AF were excluded. The drug regimen at baseline consisted of diuretics in 51 patients (46%), digitalis in 52 (47%), angiotensinconverting enzyme (ACE) inhibitors in 37 (34%) and beta-blockers in four (4%). Medical therapy during follow-up was determined by the referring physicians and was based on the clinical symptoms and course of the disease, but there was no difference in beta-blocker use or ACE inhibitor use over the course of the study. The study protocol was approved by the appropriate institutional review committee. Each patient gave written informed consent before entering the study. Cardiac catheterization. All medications were withheld for the three days before the study. Selective coronary angiography, left ventriculography, and cardiac biopsy were performed by the femoral approach to confirm the diagnosis of DCM. Of the 114 patients, 47 were selected randomly to assess myocardial energetics. Because accurate assessment of LV energetics requires an invasive protocol with extensive instrumentation, we aimed to prove a prognostic value of myocardial energetics using the minimum number of patients. A double-thermister catheter (model CCS/GOK, Hilton-Webster Laboratories, Baldwin Park, California) was placed in the coronary sinus through the brachial or subclavian vein to measure myocardial blood flow. After left ventriculography, when LV end-diastolic pressure returned to baseline values, an eight-electrode volume conductance catheter with a micromanometer tip (Leycom, Zoetermeer, The Netherlands) was advanced to the LV to measure the LV volume and pressure. A Fogarty catheter was placed in the inferior vena cava and inflated transiently to determine the LV end-systolic pressure-volume relationship. Arterial and coronary sinus blood samples were drawn simultaneously to measure the oxygen saturation. The LV pressure-volume data analysis. A volumeconductance catheter was connected to a volumetric system (model Sigma 5, Leycom, Oestgeest, The Netherlands) to measure the LV volume conductance and convert it to the LV volume. The LV volume obtained by the conductance method was calibrated by biplane ventriculography (arealength method) as described previously (8, 9 ). An endsystolic pressure-volume line was drawn on the left upper corner of the pressure-volume loops of the initial 5 to 14 contractions during the transient decrease in preload caused by the inflation of a Fogarty catheter. The LV contractility index (Ees) was defined as the slope of the end-systolic pressure-volume line (15) . The pressure-volume area (PVA) was defined as the area under the end-systolic pressurevolume line and the systolic pressure-volume trajectory and the end-diastolic pressure-volume relation curve. External work (EW) was defined as the area within the pressurevolume diagrams. The PVA and EW were measured in millimeters of mercury (mm Hg) times milliliters and converted to the dimensions of energy using the following formula:
Myocardial oxygen consumption. Myocardial blood flow was measured using a double-thermister catheter. The coronary sinus flow was calculated according to the method of Ganz et al. (17) using a computer system as described in previous studies (8, 9) . Myocardial oxygen consumption per minute was calculated as the product of coronary sinus flow and the arterial-coronary sinus oxygen content difference. Myocardial oxygen consumption per beat (VO 2 ) was calculated as follows:
͑VO 2 ͓J/beat͔͒ ϭ ͑20⅐myocardial oxygen consumption/heart rate) where 1 ml O 2 ϭ 20 J (16). Mechanical efficiency (ME) was defined as the dimensionless ratio of EW to VO 2 .
Clinical and follow-up data. Demographic data at study entrance were assessed by review of the visit and hospital records. Survival and symptomatic status at follow-up were also determined from review of this visit and hospital records, when available, or by telephone contact with patients, relatives, or the referring physician. A standard questionnaire was used for the follow-up interviews. Statistical analysis. Data are expressed as the mean value Ϯ SD. Differences between survivors and nonsurvivors were assessed using the unpaired t test, or chi-square analysis, as appropriate. Cumulative survival estimates were calculated using the Kaplan-Meier method, with differences between the survival curves assessed by the log-rank test. To identify the independent predictors of survival, the Cox proportional hazards survival model was performed at the significant variables by stepwise multiregression analysis. Receiver-operating characteristic curves were constructed, and a jackknife procedure was used to assess how well the cutoff worked. A p value Ͻ 0.05 was considered statistically significant.
RESULTS
Patient characteristics. Patients were followed for an average of 5.8 years (range 0.7 to 10.9 years) starting from the catheterization and ending with a cardiac event or the most recent data on the survivors. During the follow-up period, a total of 114 patients (range 23 to 65 years; mean age 50 Ϯ 12 years) were followed. Of these patients, four were excluded because they died of non-cardiac causes. Nineteen died of cardiac causes (16 patients with progressive heart failure and 3 with sudden death). The 3-, 5-and 10-year cumulative survival rates were 88.6%, 80.0% and 73.9%, respectively (Fig. 1 ). There were no differences in the number of patients with a familial history of DCM or sudden death, exercise duration during treadmill tests, or the occurrence of ventricular tachycardia between the survivors and nonsurvivors. Hemodynamics and myocardial energetics. We randomly selected 47 of the 114 patients to assess the parameters of myocardial energetics. None of the selected 47 patients died of non-cardiac causes. The selected group of 47 patients had a somewhat better prognosis than the entire group of 110 patients, although the difference was not significant (p ϭ 0.24; Fig. 1 ). There was no difference in the clinical and hemodynamic characteristics between the entire group of 110 patients and the selected group of 47 patients (Table 1 ).
In the selected group, the LVEF was 37.1 Ϯ 12.0%, the Ees was 1.20 Ϯ 0.64 mm Hg/ml, and the ME (EW/VO 2 ) was 20.8 Ϯ 14.2%. These values were lower than normal in our laboratory (18 -20) . There were significant differences in the LVEF, the maximum first derivative of LV pressure (LV dP/dt max), effective arterial elastance, PVA, EW, VO 2 and myocardial energy conversion (PVA/VO 2 ) between the survivors and nonsurvivors (Table 2 ). In addition, the ME in the nonsurvivors was extremely depressed compared with the survivors (8.5 Ϯ 2.2% vs. 22.7 Ϯ 15.1%, respectively). Univariate analysis of nonsurvivors. The findings of the stepwise linear regression analysis for predicting mortality from the measured variables indicated that the best predictors of mortality were the ME (chi-square to remove 5.53; p Ͻ 0.01), LVEF (chi-square to remove 7.06; p Ͻ 0.01) and LV end-diastolic pressure (chi-square to remove 4.75; p Ͻ 0.01). Cox proportional-hazard regression analysis was performed on ME, LVEF and LV end-diastolic pressure. Figure 1 . Kaplan-Meier survival curves for cardiac mortality of a larger cohort of 110 patients (A), those of 47 selected patients who underwent myocardial energetics measurements (B) and those of patients grouped according to mechanical efficacy (ME) (C: ME Ն11%, D: ME Ͻ11%). Data are presented as the mean value Ϯ SD or percentage of patients. CI ϭ cardiac index; DBP ϭ diastolic blood pressure; Ea ϭ effective arterial elastance; Ees ϭ end-systolic elastance; EW ϭ external work; EW/PVA ϭ work efficiency; EW/VO 2 ϭ mechanical efficiency; HR ϭ heart rate; PAWP ϭ pulmonary artery wedge pressure; PVA ϭ pressure-volume area; SBP ϭ systolic blood pressure; VO 2 ϭ myocardial oxygen consumption. Other abbreviations as in Table 1 .
Mechanical efficiency was the most important and independent variable for predicting survival (p ϭ 0.011). The LVEF and LV end-diastolic pressure were the next best predictive variables but were not significant (p ϭ 0.058, p ϭ 0.884, respectively). Prognostic significance of mechanical efficiency. To evaluate the further prognostic significance of the ME, a receiver operating characteristic curve was constructed, and it indicated that the best cutoff value for the ME was 11%. This value had a sensitivity of 100%, a specificity of 87% and an overall predictive accuracy of 88% in distinguishing survivors from nonsurvivors using the jackknife procedure. The patients whose ME was Ͻ11% had a significantly reduced five-year survival rate of 58.3% compared with those whose ME was Ն11%, who had a five-year survival rate of 100% (p Ͻ 0.001; Fig. 1 ).
DISCUSSION
Despite recent improvements in the medical management of patients with DCM, the overall prognosis is still poor, and heart transplantation often represents the only lifesaving therapeutic option for these patients (1,2,4). Several investigators (2-5) have tried to identify prognostic factors that might predict a poor outcome in these patients in an attempt to select patients appropriately for heart transplantation or for more aggressive forms of treatment. Unfortunately, no factor has proven to predict unequivocally the risk of cardiac death or the need for heart transplantation. This study is the first to report that an ME Ն11% is an independent clinical predictor for survival in patients with mild to moderate DCM in sinus rhythm. Mechanoenergetic uncoupling in DCM. The ME of the LV is defined as the fraction of total expended metabolic energy that is converted into external contractile work (21) . The concept of ME includes information not only about cardiac output but also about the concomitant energy cost. Mechanical efficiency has been used mainly to assess and optimize the effects of medical therapy in patients with heart failure, and it has been suggested that ME is a very sensitive parameter for characterizing LV performance by taking into account the energy cost for a given level of cardiac output (8, 9, 22) , which may support our current findings. In heart failure, the oxygen cost of contraction remains relatively unchanged, despite markedly impaired LV work, resulting in a decrease in the ME of contraction. In fact, in the present study, patients with mild to moderate DCM in sinus rhythm showed a remarkable decrease in the ME defined as the ratio of external work to myocardial oxygen consumption. Therefore, patients with DCM are characterized by mechanoenergetic uncoupling, which is an imbalance between LV performance and myocardial energy consumption.
Comparison with previous studies. In most studies of survival in DCM, the LVEF is undoubtedly the factor that has received the most attention (2-4) . In previous studies, the LVEF was the single independent prognostic factor, although other studies either did not support this observation (23, 24) or found that the LVEF was less predictive than other parameters such as the Doppler-derived dP/dt (25) or the transmitral inflow characteristics (5) . In a previous study (4) , an LVEF Ͻ20% was associated with a one-year mortality of 30% in patients with DCM. Actually, both the LVEF and the directly measured peak-positive dP/dt were significantly higher in survivors than in nonsurvivors in the present study. However, we could not confirm these variables to be significant prognostic predictors. These differences may be explained by differences in the patient populations. It is noteworthy that our patients showed a favorable prognosis; the 5-year mortality was 20%, and the 10-year mortality was 26%. Our study consisted of a less severely afflicted, ambulatory population of patients whose mean LVEF was about 40% and had sinus rhythm. Over 70% of our patients were in New York Heart Association (NYHA) functional class I and II, but most previous studies were based on an analysis of patients in NYHA functional class III and IV. In addition, most previous studies included patients with AF.
Recent data in humans (11) have demonstrated that the persistent irregularity in ventricular cycle lengths resulting from AF adversely affects ventricular function and the hemodynamic status, independent of the effect of AF upon the ventricular rate. More recently, the presence of AF with heart failure has been demonstrated (12) to be independently associated with an increased risk for mortality. Thus, we believe that our study is the first to demonstrate clearly that ME is an important and powerful prognostic predictor in clinically stable and ambulatory patients with DCM in sinus rhythm. Study limitations. Several methodological problems must be discussed. First, the number of patients enrolled in the present study was relatively small. In addition, this study was performed in clinically stable and ambulatory patients in sinus rhythm. Therefore, the results cannot be widely extrapolated to patients with more severe LV dysfunction. Further studies of larger numbers of patients are needed before these conclusions can be applied more generally to patients with LV dysfunction. Second, we assumed that the LV volume obtained by the conductance catheter could be reliable. It has been reported that the conductance catheter may underestimate real volume when calibrated by using blood conductivity and measuring parallel conductance by injection of hypertonic saline solution (26, 27) . However, in our previous study (8) , we demonstrated the reproducibility of measurements obtained by the same method as in the present study. Furthermore, other methods of measuring LV volume, such as two-dimensional echocardiogram or radioisotope angiography, also have some limitations. Conclusions. The present study can provide valuable prognostic information in DCM patients in sinus rhythm with mild to moderate LV dysfunction. The principal new finding of the present study is that the assessment of ME is
